Wyeth receives authorisation for Prevenar vaccine in Russia
This article was originally published in Scrip
Executive Summary
Wyeth has received a marketing authorisation for its Prevenar vaccine against seven serotypes of Streptococcus pneumoniae from Russia's healthcare authorities. The product is expected to reach the market later in the year.